Wall Street Experts
ver. ZuMIgo(08/25)
GeneDx Holdings Corp.
Rachunek Zysków i Strat
Przychody TTM (mln): 267
EBIT TTM (mln): -81
| index |
0 |
1 |
2 |
3 |
4 |
5 |
| Rok finansowy |
2019 |
2020 |
2021 |
2022 |
2023 |
2024 |
| Przychód (mln) |
196 |
179 |
212 |
235 |
203 |
305 |
| Przychód Δ r/r |
0.0% |
-8.6% |
18.3% |
10.6% |
-13.7% |
50.8% |
| Marża brutto |
42.2% |
2.2% |
-7.8% |
-11.4% |
29.9% |
63.6% |
| EBIT (mln) |
-30 |
-242 |
-446 |
-668 |
-164 |
-23 |
| EBIT Δ r/r |
0.0% |
695.7% |
84.4% |
49.6% |
-75.5% |
-85.8% |
| EBIT (%) |
-15.5% |
-134.9% |
-210.3% |
-284.5% |
-80.8% |
-7.6% |
| Koszty finansowe (mln) |
1 |
2 |
3 |
3 |
0 |
-3 |
| EBITDA (mln) |
-23 |
-227 |
-424 |
-396 |
-128 |
-23 |
| EBITDA(%) |
-11.5% |
-126.7% |
-200.0% |
-168.6% |
-63.1% |
-7.6% |
| Podatek (mln) |
1 |
5 |
0 |
-49 |
-1 |
-0 |
| Zysk Netto (mln) |
-31 |
-246 |
-245 |
-549 |
-176 |
-52 |
| Zysk netto Δ r/r |
0.0% |
695.2% |
-0.4% |
123.7% |
-68.0% |
-70.3% |
| Zysk netto (%) |
-15.8% |
-137.4% |
-115.6% |
-233.9% |
-86.8% |
-17.1% |
| EPS |
-4.26 |
-1584951.85 |
-74.93 |
-53.63 |
-7.23 |
-1.94 |
| EPS (rozwodnione) |
-4.26 |
-1584951.85 |
-74.93 |
-53.63 |
-7.23 |
-1.94 |
| Ilośc akcji (mln) |
7 |
0 |
3 |
10 |
24 |
27 |
| Ważona ilośc akcji (mln) |
7 |
0 |
3 |
10 |
24 |
27 |
| Waluta |
USD |
USD |
USD |
USD |
USD |
USD |